Non-Alcoholic Steatohepatitis (NASH) is a real health problem that is commonly associated with obesity and diabetes. Cardiovascular diseases, liver carcinoma, and liver failure might develop from NASH if not well managed. The present article deals with the pathogenesis of non-alcoholic steatohepatitis and its complications in addition to exploring the importance of using nutraceuticals in its prevention and treatment.
No takes yet. Share an insight, caveat, or question.
Al-Okbi Sahar Y (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: